PR Newswire | Aug 9, 2021 08:02AM EDT

Financial Results and Business Highlights Conference Call

08/09 07:00 CDT

Arcadia Biosciences (RKDA) Announces Date of Second-Quarter and First-Half 2021 Financial Results and Business Highlights Conference Call DAVIS, Calif., Aug. 9, 2021

DAVIS, Calif., Aug. 9, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc.(r) (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the second quarter and first half 2021 after market close on August 16, 2021.

The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss second-quarter results and key strategic achievements. Interested participants can join the conference call using the following numbers:

U.S. Toll-Free Dial-In: +1-844-243-4690 International Dial-In: +1-225-283-0138Passcode: 3389334

A live webcast of the conference call will be available on the Investors section of Arcadia's website at www.arcadiabio.com. Following completion of the call, a recorded replay will be available on the company's investor website.

About Arcadia Biosciences, Inc.With origins as a trailblazing developer of science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, Arcadia Biosciences (Nasdaq: RKDA) is now a producer of innovative, plant-based health and wellness products, within the portfolios of GoodWheat(tm) and Lief(tm), which includes popular brands Soul Spring(tm), ProVault(tm), Saavy Naturals(tm) and Zola(r) coconut water. The company's growing number of innovative offerings are designed to enhance quality and health benefits in an array of consumer product categories. For more information, visitwww.arcadiabio.com.

View original content to download multimedia: https://www.prnewswire.com/news-releases/arcadia-biosciences-rkda-announces-date-of-second-quarter-and-first-half-2021-financial-results-and-business-highlights-conference-call-301350611.html

SOURCE Arcadia Biosciences, Inc.